Annual report pursuant to Section 13 and 15(d)

Stockholders Equity (Details) - Schedule of stock-based payment expenses

v3.22.1
Stockholders Equity (Details) - Schedule of stock-based payment expenses - Selling, General and Administrative Expenses [Member] - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Research and development expenses, net $ 1,770 $ 1,815
General and administrative 1,467 1,075
Total $ 3,237 $ 2,890